IBL Finance IPO is entirely a fresh issue of up to 67.25 lakh equity shares aggregating up to Rs 34.3 crore. The company is offering its shares at Rs 51 apiece, and investors can bid for 2,000 shares in one lot.
The company is engaged in the business of marketing and distributing pharmaceutical products. It works with various contract manufacturers, who make pharmaceutical products based on compositions given by the company, and subsequently it sells those products under the brand "DLS Export".